Literature DB >> 12389082

Opposite effects of testosterone and estrogens on chronic allograft nephropathy.

Balazs Antus1, Yousheng Yao, Erwei Song, Shanying Liu, Jens Lutz, Uwe Heemann.   

Abstract

In the present study we investigated whether donor gender or the effects of sex hormones play the greater role in the development of chronic allograft nephropathy. Kidneys of male and female Fisher rats were orthotopically transplanted into castrated male Lewis recipients. Animals were treated with testosterone, estradiol, or vehicle and the kidneys were harvested 20 weeks after transplantation for histological, immunohistological, and molecular analysis. Testosterone treatment resulted in increased proteinuria and profound glomerulosclerosis, irrespective of donor gender. In addition, mRNA levels of transforming growth factor-beta1 (TGF-beta1) and platelet-derived growth factor-A and B (PDGF-A and B) chains were enhanced in these allografts. Estradiol reduced glomerulosclerosis and mononuclear cell infiltration in allografts of both genders that paralleled a decreased mRNA expression of TGF-beta1, PDGF-A and B. No donor gender-related differences were noted in vehicle-treated animals. Our findings demonstrate that sex hormones rather than donor gender have a significant impact on chronic allograft nephropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12389082     DOI: 10.1007/s00147-002-0449-2

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Improved renal ischemia tolerance in females influences kidney transplantation outcomes.

Authors:  David D Aufhauser; Zhonglin Wang; Douglas R Murken; Tricia R Bhatti; Yanfeng Wang; Guanghui Ge; Robert R Redfield; Peter L Abt; Liqing Wang; Nikolaos Svoronos; Arwin Thomasson; Peter P Reese; Wayne W Hancock; Matthew H Levine
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

2.  Urinary proteomic analysis of chronic allograft nephropathy.

Authors:  Edmond O'Riordan; Tatyana N Orlova; Natalia Mendelev; Daniel Patschan; Rowena Kemp; Praveen N Chander; Rena Hu; Gang Hao; Steven S Gross; Renato V Iozzo; Veronica Delaney; Michael S Goligorsky
Journal:  Proteomics Clin Appl       Date:  2008-07       Impact factor: 3.494

3.  Identification of patients at risk for renal impairment after living donor kidney transplantation.

Authors:  Alexander Kaltenborn; Almut Nolte; Ysabell Schwager; Simon A Littbarski; Nikos Emmanouilidis; Viktor Arelin; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2016-08-09       Impact factor: 3.445

4.  Preventive role of estradiol on kidney injury induced by renal ischemia-reperfusion in male and female rats.

Authors:  Akram Iran-Nejad; Mehdi Nematbakhsh; Fatemeh Eshraghi-Jazi; Ardeshir Talebi
Journal:  Int J Prev Med       Date:  2015-03-20

5.  Male kidney allograft recipients at risk for urinary tract infection?

Authors:  Gerold Thölking; Katharina Schuette-Nuetgen; Thomas Vogl; Ulrich Dobrindt; Barbara C Kahl; Marcus Brand; Hermann Pavenstädt; Barbara Suwelack; Raphael Koch; Stefan Reuter
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

6.  Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study.

Authors:  Mirza Saim Baig; Agnieszka Kolasa-Wołosiuk; Anna Pilutin; Krzysztof Safranow; Irena Baranowska-Bosiacka; Joanna Kabat-Koperska; Barbara Wiszniewska
Journal:  Int J Environ Res Public Health       Date:  2019-05-16       Impact factor: 3.390

7.  Analysis of Factors Influencing Kidney Function of Recipients After Renal Transplantation in Southwestern China: A Retrospective Study.

Authors:  Zhaodan Xin; Lijuan Wu; Juan Zhou; Jie Zhuang; Wu Peng; Turun Song; Tao Lin; Xiaojun Lu; Binwu Ying
Journal:  Front Med (Lausanne)       Date:  2020-11-12

8.  Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?

Authors:  David A Sullivan; Roderick V Jensen; Tomo Suzuki; Stephen M Richards
Journal:  Mol Vis       Date:  2009-08-10       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.